#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoidosis Still's disease Leukocyte adhesion deficiency type I Blood iron increased Renal disorder Palmar-plantar erythrodysaesthesia syndrome Desmoid tumour Progressive familial intrahepatic cholestasis Mitochondrial myopathy Osteosarcoma recurrent Vulval cancer recurrent Severe myoclonic epilepsy of infancy Heart disease congenital Synovial sarcoma metastatic Lymphangioma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Diagnostics Bronchiolitis obliterans syndrome – Life with Disease Rett syndrome – Diagnostics Antisynthetase syndrome – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Rosai-Dorfman syndrome – Diagnostics Myelodysplastic syndrome – Trials in Disease Mantle cell lymphoma refractory – Diagnostics Haemophilia A without inhibitors – Basic Information Angiosarcoma non-metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HUMAN PLASMA Vusolimogene Oderparepvec Felzartamab 13N-AMMONIA Pamapimod SODIUM FUSIDATE Ale.c04 Ambrisentan Glpg3667 Fumarate Serine Danicamtiv Fostemsavir Trometamol Afamelanotide Pemigatinib GOVORESTAT Caplacizumab Doxazosin Mesilate Ima402 Opevesostat Nirogacestat Hydrobromide More therapies…

    Learn about Your Condition

    Premature rupture of membranes Fatty acid oxidation disorder Gastric cancer stage IV Haematological infection Vaginal haemorrhage Ewing's sarcoma metastatic Hepato-lenticular degeneration Vulvovaginal candidiasis Hypercholesterolaemia Nodular melanoma Nocturia Otitis media Meningioma malignant Haemoptysis Peritoneal cancer index More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Baclofen for Inpatient Detoxification in Patients with GHB Use Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Baclofen
    • Sodium Oxybate
    The Netherlands

  • Study on Protamine Sulfate to Reduce Neurological Events After Aortic Valve Implantation in Patients with Aortic Stenosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Protamine Sulfate
    France

  • Study on Indocyanine Green for Evaluating Surgical Margins in Patients Undergoing Breast-Conserving Surgery for Early Invasive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast conserving surgery
    • Invasive breast carcinoma
    Investigated Drugs:
    • Indocyanine Green
    Belgium

  • Study on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    • Subacute cutaneous lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Belgium Bulgaria France Germany Hungary Italy +5

  • Study on Customized Antibiotic Treatment Duration for Hospitalized Patients with Community-Acquired Pneumonia Using Cefotaxime and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Pristinamycin
    • Amoxicillin
    • Ceftriaxone
    France

  • Study on Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Behcet’s syndrome
    • Dermatomyositis
    Investigated Drugs:
    • Filgotinib
    The Netherlands
Previous Page
1 … 560 561 562 563 564 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!